• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未治疗的幼年皮肌炎患儿的核因子κB受体活化因子配体与骨保护素比值及骨密度

RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.

作者信息

Rouster-Stevens Kelly A, Langman Craig B, Price Heather E, Seshadri Roopa, Shore Richard M, Abbott Kathy, Pachman Lauren M

机构信息

Children's Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60614, USA.

出版信息

Arthritis Rheum. 2007 Mar;56(3):977-83. doi: 10.1002/art.22433.

DOI:10.1002/art.22433
PMID:17328075
Abstract

OBJECTIVE

To determine bone mineral density (BMD) in patients at the time of diagnosis of juvenile dermatomyositis (DM), to compare the RANKL:osteoprotegerin (OPG) ratio in patients with juvenile DM with that in healthy control subjects, and to evaluate whether BMD is associated with the RANKL:OPG ratio and the duration of untreated disease.

METHODS

Thirty-seven children with juvenile DM were enrolled. Dual x-ray absorptiometry (DXA) was performed before treatment, and Z scores for the lumbar spine (L1-L4) were determined. The duration of untreated disease was defined as the period of time from the onset of rash or weakness to the time at which DXA was performed. Serum specimens obtained at the time of DXA were analyzed for concentrations of RANKL and OPG, using enzyme-linked immunosorbent assay. The RANKL:OPG ratio was also determined in 44 age-matched healthy control subjects.

RESULTS

At the time of diagnosis of juvenile DM, patients had a significantly increased RANKL:OPG ratio compared with that in healthy children (mean +/- SD 2.19 +/- 3.03 and 0.13 +/- 0.17, respectively; P < 0.0001). In patients with a lumbar spine BMD Z score of -1.5 or lower, the RANKL:OPG ratio was significantly higher than that in patients with a lumbar spine BMD Z score higher than -1.5 (P = 0.038). Lumbar spine BMD Z scores (mean +/- SD -0.13 +/- 1.19 [range -2.10 to 2.85]) were inversely associated with the duration of untreated disease (R = -0.50, P = 0.003).

CONCLUSION

Children with juvenile DM have an elevated RANKL:OPG ratio at the time of diagnosis, resulting in expansion of the number of osteoclasts and activation of the bone resorptive function. This may lead to a lack of normal bone mineral accretion and a subsequent reduction in the lumbar spine BMD Z score. Patients with a longer duration of untreated juvenile DM have reduced lumbar spine BMD Z scores. These data suggest that early diagnosis could reduce the likelihood of reduced lumbar spine BMD in these patients by prompting intervention strategies at an early stage.

摘要

目的

测定青少年皮肌炎(DM)患者诊断时的骨密度(BMD),比较青少年DM患者与健康对照者的核因子κB受体活化因子配体(RANKL):骨保护素(OPG)比值,并评估BMD是否与RANKL:OPG比值及未治疗疾病的持续时间相关。

方法

纳入37例青少年DM患儿。治疗前进行双能X线吸收测定(DXA),并确定腰椎(L1-L4)的Z值。未治疗疾病的持续时间定义为从皮疹或肌无力发作至进行DXA的时间段。使用酶联免疫吸附测定法分析DXA时采集的血清标本中RANKL和OPG的浓度。还测定了44例年龄匹配的健康对照者的RANKL:OPG比值。

结果

青少年DM诊断时,患者的RANKL:OPG比值显著高于健康儿童(分别为均值±标准差2.19±3.03和0.13±0.17;P<0.0001)。腰椎BMD Z值为-1.5或更低的患者,其RANKL:OPG比值显著高于腰椎BMD Z值高于-1.5的患者(P=0.038)。腰椎BMD Z值(均值±标准差-0.13±1.19[范围-2.10至2.85])与未治疗疾病的持续时间呈负相关(R=-0.50,P=0.003)。

结论

青少年DM患儿诊断时RANKL:OPG比值升高,导致破骨细胞数量增加和骨吸收功能激活。这可能导致正常骨矿物质积累不足,随后腰椎BMD Z值降低。未治疗的青少年DM持续时间较长的患者腰椎BMD Z值降低。这些数据表明,早期诊断通过促使早期干预策略,可降低这些患者腰椎BMD降低的可能性。

相似文献

1
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.未治疗的幼年皮肌炎患儿的核因子κB受体活化因子配体与骨保护素比值及骨密度
Arthritis Rheum. 2007 Mar;56(3):977-83. doi: 10.1002/art.22433.
2
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.绝经后女性血清核因子-κB 受体活化因子配体、骨保护素、高敏 C 反应蛋白与骨密度之间的关系:骨免疫与骨炎症
Menopause. 2009 Sep-Oct;16(5):950-5. doi: 10.1097/gme.0b013e3181a181b8.
3
Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?青少年特发性关节炎中的骨保护素(OPG)/核因子κB受体活化因子配体(RANK-L)系统:OPG/RANK-L在骨损伤中是否具有潜在的调节作用?
J Rheumatol. 2004 May;31(5):986-91.
4
Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker?活动性多关节起病型幼年特发性关节炎中骨保护素/核因子κB受体活化因子配体系统失衡:一种骨损伤生物标志物?
Scand J Rheumatol. 2008 Nov-Dec;37(6):439-44. doi: 10.1080/03009740802116224.
5
Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.异基因造血干细胞移植后骨髓微环境中骨保护素/核因子κB受体活化因子配体比值失衡。
Transplantation. 2006 Dec 15;82(11):1449-56. doi: 10.1097/01.tp.0000244588.42519.72.
6
Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.接受原位肝移植的肝硬化患者血清骨保护素及其配体:与代谢性骨病的关系
Liver Int. 2007 May;27(4):492-7. doi: 10.1111/j.1478-3231.2007.01448.x.
7
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.测量老年女性骨代谢中核因子-κB 受体活化因子配体和骨保护素的可溶性受体的意义
Gerontology. 2009;55(3):275-80. doi: 10.1159/000196280. Epub 2009 Jan 22.
8
The RANKL/OPG system and bone mineral density in patients with chronic liver disease.慢性肝病患者的RANKL/OPG系统与骨密度
J Hepatol. 2005 Dec;43(6):973-83. doi: 10.1016/j.jhep.2005.05.034. Epub 2005 Jul 5.
9
Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.骨保护素和核因子κB受体活化因子配体在重型地中海贫血患者骨质疏松发病机制中的作用
Panminerva Med. 2009 Mar;51(1):17-23.
10
Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus.血清 RANKL、骨保护素(OPG)及 RANKL/OPG 比值与系统性红斑狼疮患儿的相关性研究
Lupus. 2019 Sep;28(10):1233-1242. doi: 10.1177/0961203319867129. Epub 2019 Aug 12.

引用本文的文献

1
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.埃及幼年特发性关节炎患儿的骨密度:与血清 RANKL/骨保护素(OPG)比值和 OPG 基因多态性的相关性。
Pediatr Rheumatol Online J. 2023 Jun 16;21(1):58. doi: 10.1186/s12969-023-00843-6.
2
Bone remodeling serum markers in children with systemic lupus erythematosus.系统性红斑狼疮患儿的骨重建血清标志物。
Pediatr Rheumatol Online J. 2022 Jul 27;20(1):54. doi: 10.1186/s12969-022-00717-3.
3
Genetic Association of rs1021188 and DNA Methylation Signatures of in the Risk of Conductive Hearing Loss.
rs1021188的基因关联及DNA甲基化特征与传导性听力损失风险的关系
Front Med (Lausanne). 2022 Apr 18;9:870244. doi: 10.3389/fmed.2022.870244. eCollection 2022.
4
Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.青少年皮肌炎:诊断与治疗的新线索
Curr Treatm Opt Rheumatol. 2021 Mar;7(1):39-62. doi: 10.1007/s40674-020-00168-5. Epub 2021 Feb 6.
5
Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study.儿童和青少年皮肌炎患者长期随访的骨密度及其影响因素;一项横断面研究。
Pediatr Rheumatol Online J. 2021 Apr 26;19(1):56. doi: 10.1186/s12969-021-00543-z.
6
Myostatin and markers of bone metabolism in dermatomyositis.皮肌炎中的肌生成抑制素与骨代谢标志物
BMC Musculoskelet Disord. 2021 Feb 5;22(1):150. doi: 10.1186/s12891-021-04030-0.
7
The risk of fracture and prevalence of osteoporosis is elevated in patients with idiopathic inflammatory myopathies: cross-sectional study from a single Hungarian center.特发性炎性肌病患者骨折风险及骨质疏松患病率升高:来自匈牙利单一中心的横断面研究
BMC Musculoskelet Disord. 2020 Jul 2;21(1):426. doi: 10.1186/s12891-020-03448-2.
8
Calcinosis Biomarkers in Adult and Juvenile Dermatomyositis.成人和青少年皮肌炎中的钙沉积标志物。
Autoimmun Rev. 2020 Jun;19(6):102533. doi: 10.1016/j.autrev.2020.102533. Epub 2020 Mar 28.
9
Evaluating RANKL and OPG levels in patients with Duchenne muscular dystrophy.评估杜氏肌营养不良症患者的 RANKL 和 OPG 水平。
Osteoporos Int. 2019 Nov;30(11):2283-2288. doi: 10.1007/s00198-019-05077-5. Epub 2019 Aug 7.
10
Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.保护儿童风湿性疾病中的骨骼健康:药理学考量
Paediatr Drugs. 2017 Jun;19(3):193-211. doi: 10.1007/s40272-017-0219-3.